National Institute on Drug Abuse (NIDA)

On this page:

Mission Statement

The NIDA Mission is to advance science on drug use and addiction and to apply that knowledge to improve individual and public health.

Interest Areas

General Topics

  • Characterize properties of emerging drugs/drug combinations and their targets in the brain and periphery
  • Develop new approaches to identify emerging drugs; improve the timeliness of data on drug use, substance use disorder (SUD), overdose and other outcomes; understand drivers of overdose mortality trends
  • Examine factors influencing risk/resilience for substance use and SUD and translate this knowledge into prevention interventions
  • Understand mechanisms of SUD, recovery, and relapse to identify new targets for intervention
  • Identify trajectories from drug use to SUD to inform personalized interventions
  • Advance research on neuroplasticity towards interventions for SUD and its consequences
  • Advance research on neurobiological overlap between pain and SUD to inform interventions
  • Develop strategies to minimize opioid use disorder (OUD) risk in the context of pain treatment and improve care for people with OUD and chronic pain
  • Advance solutions to disparities in SUD risk, outcomes, and access to care among hard-to-reach and rural populations
  • Develop SUD and overdose prevention, treatment, and recovery interventions, and strategies to integrate care across SUD settings
  • Advance patient-centered endpoints for clinical trials, including reduction in craving and other SUD symptoms
  • Use data science and AI to develop clinical decision support tools and identify gaps in healthcare services for SUD and overdose
  • Advance polysubstance use research and treatment for concurrent SUDs
  • Develop new approaches to reduce overdose risk
  • Evaluate recovery support services and models for delivering these services
  • Advance research on co-occurring SUD and mental health disorders, including on co-treatment models
  • Advance research on SUD and HIV, including on how drug use affects HIV transmission/progression and related interventions
  • Advance the training of a multidisciplinary new generation of scientists

Assistance Listing

Assistance listings are detailed public descriptions of federal programs used across government agencies that provide grants, loans, scholarships, insurance, and other types of assistance awards. They are maintained in the System for Award Management (SAM) and can be used to search for opportunities in Grants.gov.

View NIDA Assistance Listing Numbers

  • 93.279 - Drug Use and Addiction Research Programs

Highlighted Topics

Title Lead ICO Participating ICOs Posted Date Expiration Date

Funding Opportunities and Notices

Search for NIDA’s funding opportunities and notices

Additional Information by Funding Category

Administrative Supplements
In addition to our Administrative Supplements overview, consider the following NIDA-specific information.
Administrative Supplement Interest Areas:
  • NIDA recommends interested applicants reach out to their current program officer as listed on the Notice of Award for the most recent parent award to discuss whether a supplement request would be appropriate
  • Administrative supplement requests above $99,999 in direct costs will be reviewed by the National Advisory Council on Drug Abuse.
Administrative Supplement Due Dates:

NIDA accepts administrative supplement requests on a continuous basis but will consider them for funding four times a year; December, February, May and August. The final submission date for each fiscal year is July 1.

Administrative Supplement Contact:

Chief Grants Management Officer
National Institute of Drug Abuse (NIDA)
Email: [email protected] 

See Also

National Institute on Drug Abuse (NIDA)

For technical issues E-mail OER Webmaster